Clinical trials
Completed Phase 1/2 trials in Lithuania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cantargia AB | 1 |
| Daiichi Sankyo | 1 |
| GlaxoSmithKline | 1 |
| Ipsen | 1 |
| Lithuanian University of Health Sciences | 1 |
| Takeda | 1 |
| Tigenix S.A.U. | 1 |
| Zeno Alpha Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 2 |
| Acromegaly | 1 |
| Breast Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Infections | 1 |
| Lung Neoplasms | 1 |
| Neoplasms | 1 |
| Pneumonia, Bacterial | 1 |
| Sepsis | 1 |
| Shock, Septic | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.